novo nordisk glp-1 receptor agonist Oral Semaglutide Approved to Reduce the Risk of Cardiovascular Events Novo Nordisk GLP-1 Drug Meets
Description
The serosal mesothelium is a major source of smooth muscle cells of the gut vasculature
[DOI] [PMC free article] [PubMed] [Google Scholar] 26.Knop FK, Urva S, Rettiganti M, Benson CT, Roell WC, Mather KJ, et al
Availability of Data and Material Data are available on request from the authors
Retrieved from Poulimeneas, D., Anastasiou, C
It's essential to inform the healthcare provider about any pre-existing medical conditions, allergies, or medications being taken before starting GLP-1 therapy
